Storia Naturale E Clinica Dei Tumori Neuroendocrini Digestivi

Bordi C. , D'Adda T. , Azzoni C. , Ferraro G. : Pathogenesis of ECL tumors in humans. Yale J. Biol. Med., 71: 273–284, 1994.

Jensen R.T. , Norton J.A. : Endocrine tumors of the pancreas. In: Gastrointestinal and liver disease, Feldman M. , Scharschmidt B.F. , Sleisenger M.H. (Eds.), pp. 871–889, W.B. Saunders, Philadelphia, 1998.

Jensen R.T. : Use of omeprozole and other proton pump inhibitors in the Zollinger-Ellison syndrome. In: Milestones in drug therapy, Olbe L. (Ed.), Birkhausen Verlog AG Publish Co., pp. 205–221, Basel, 1998.

Kloppel G. , Heitz P.U. : Classification of normal and neoplastic neuroendocrine cells. Ann. NY Acad. Sci., 733: 18–23, 1994.

Madeira I. , Terris B. , Voss M. , Denys A. , Sauvanet A. , Flejou J.F. , Vilgrain V. , Belghiti J. , Bernades P. , Ruszniewski P. : Prognostic factors in patients with endocrine tumors of the duodenopancreatic area. Virchows Arch., 429: 323–333, 1996.

Mignon M. , Colombel J.F. (Eds.): Recent advances in the pathophysiology and management of inflammatory bowel diseases and digestive endocrine tumors. John Libbey and Co, London, 1999.

Weber H.C. , Venzon D.J. , Lin J.T. , Fishbein VA , Orbuch M. , Strader DB , Gibril F. , Metz DC , Franker D.L. , Norton J.A. : Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long term study. Gastroenterology, 108: 1637–1649, 1995.

Yu F. , Vanzon D.J. , Serrano J. , Goebel S.U. , Doppman J.L. , Gibril F. , Jensen R.T. : Prospective study of the clinical course, prognostic factors and survival in patients with longstanding Zollinger-Ellison syndrome. J. Clin. Oncol.; 17: 615–630, 1999.